We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The agency found that the material used to stopper bottles under vacuum and for lyophilization of soft tissue was not tested for microorganisms. Read More
NPPA issued the new memorandum after it received a request from Abbott Healthcare to withdraw its coronary stents from the market because of “commercial unviability.” Read More
The system is designed for non-invasive retrograde flushing the ventricular catheter with the goal of restoring or increasing cerebrospinal fluid. Read More
The FDA issued a warning to Florida-based ProSun International, a tanning bed manufacturer, over significant GMP and branding violations revealed during an August inspection. Read More
A medical device manufacturer in Yokneam, Israel failed to submit adverse event reports to the FDA within 30 days after becoming aware of numerous complaints that warranted them, the agency said. Read More